Zydus Lifesciences Q3 Results
- BSE: 532321
- NSE: ZYDUSLIFE
- ISIN: INE010B01027
- Sector: Biotechnology & Drugs
BSE
1,086.85
-2.05 (-0.19%)
-2.05 (-0.19%)Volume48.73 K
Updated: Mon 8 Jun, 2026 | 15:29:34
NSE
1,087.60-1.40 (-0.13%)
-1.40 (-0.13%)Volume8.30 L
Updated: Mon 8 Jun, 2026 | 15:50:37
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 25
Note: Comparison is on QoQ basis
Quarterly - Zydus Lifesciences Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 5,657.00 | 4,054.60 | 16.46% | 3,618.20 | 31.77% |
| Depreciation/ Amortization | 359.60 | 233.60 | 19.11% | 194.80 | 57.03% |
| Operating Income | 1,207.50 | 1,182.40 | -4.59% | 887.00 | 23.72% |
| Net Income | 1,042.10 | 911.20 | -17.20% | 789.60 | 1.82% |
| Other Operating Expenses Total | 2,236.50 | 1,470.40 | 24.47% | 1,137.60 | 45.78% |
| Net Income Before Taxes | 1,353.40 | 1,270.90 | -19.79% | 925.50 | 14.30% |
| Total Revenue | 6,864.50 | 5,237.00 | 12.11% | 4,505.20 | 30.28% |
| Selling/ General/ Admin Expenses Total | 1,139.70 | 879.20 | 10.20% | 817.30 | 20.41% |
| Diluted Normalized EPS | 10.96 | 9.06 | -14.08% | 7.58 | 7.75% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.